ArticleBrazilian journal of biometrics2022

Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value?

Mourad Tighiouart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.